R
Power Law company profile
Recursion Pharma
Biotech & Life Sciences · Salt Lake City, United States · Founded 2013 · IPO 2021 Unicorn
Valuation
$1.08B
Market cap · Apr/2026
Revenue
$74M
Latest reported FY
Global footprint
Where Recursion Pharma has talent and traffic
AI talent share
8.8%
of workforce is AI talent
(83 of 942 staff)
(83 of 942 staff)
Core AI373.93%
Other AI464.88%
Non-AI workforce85991.19%
Web traffic by country
81K
monthly visits
across markets
across markets
🇺🇸 United States35.3%
🏳️ Korea6.8%
🏳️ Republic of6.8%
🇬🇧 United Kingdom6.4%
🇨🇦 Canada4.4%
Patent intelligence
$13M patent portfolio · 96 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$13M
1.2% of market cap · 203.5× smaller than top peer Illumina ($2.7B)
96 active patent families
Where Recursion Pharma innovates
Learning modelsData miningBioinformaticsVivariumDisease
Above peer median on Legal · Below peer median on Market
Quality vs same-sector peers
Recursion Pharma on the five Patsnap quality dimensions
Recursion Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Recursion Pharma concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Recursion Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Recursion Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.